Advances in therapy for adult asthma

Clinical Cornerstone

Volumn 8, Issue 4, 2008, Pages 62-75

  Gelfand, Erwin W ^a  

^a Department of Pediatrics National Jewish Medical Center Denver ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; COCAINE; CORTICOSTEROID; DIAMORPHINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; INFLUENZA VACCINE; MONTELUKAST; OMALIZUMAB; PLACEBO; TRIAMCINOLONE ACETONIDE;

ARTHRITIS; ARTICLE; ASPERGILLUS; ASTHMA; BONE DENSITY; BRONCHOPULMONARY ASPERGILLOMA; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COCAINE DEPENDENCE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORTICOSTEROID INDUCED OSTEOPOROSIS; COUGHING; CYSTIC FIBROSIS; DEPRESSION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE EXACERBATION; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; EARLY INTERVENTION; FOREIGN BODY REACTION; HEART ARREST; HEART INFARCTION; HEART MUSCLE CONTRACTILE FORCE; HEART OUTPUT; HEART RATE; HEROIN DEPENDENCE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; HYPERTENSION; INCIDENCE; INFLUENZA; LUNG FUNCTION TEST; MATERNAL HYPERTENSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OSTEOPOROSIS; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SAFETY; POTASSIUM BLOOD LEVEL; PREGNANCY; SELF CARE; SIDE EFFECT; SINUS TACHYCARDIA; SMOKING CESSATION; SOCIAL STATUS; STROKE; SUDDEN DEATH; TERATOGENICITY; TREATMENT PLANNING; UNITED STATES; VASCULAR RESISTANCE;

ADULT; ASTHMA; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 49349083889     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(08)80013-0     Document Type: Article

References (55)

1. American Lung Association, Epidemiology & Statistics Unit. Trends in Asthma Morbidity and Mortality
2. http://www.lungusa.org Accessed November 12, 2007
3. Global Initiative for Asthma. Workshop Report: Global Strategy for Asthma Management and Prevention. National Institutes of Health. NIH Publication No. 02-3659. Issued January, 1995 (updated 2002)
4. http://www.ginasthma.org Accessed March 2007
5. Sullivan S.D. The burden of uncontrolled asthma on the US Health Care System. Manag Care 14 8 Suppl (2005) 4-7
6. National Asthma Education and Prevention Program (NAEPP). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma, Full Report 2007. Bethesda, Md: National Heart, Lung, and Blood Institute; August 2007. NIH Publication 07-4051
7. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm Accessed September 10, 2007
8. US Environmental Protection Agency. Where you Live: State and Regional Indoor Environments Contact Information
9. (2006). http://www.epa.gov/iaq/whereyoulive.html Accessed March 2007
10. Reed C.E. The natural history of asthma. J Allergy Clin Immunol 118 (2006) 543-548
11. Wenzel S.E. Asthma: Defining of the persistent adult phenotypes. Lancet 368 (2006) 804-813
12. Apter A.J., and Stanley J.S. Advances in adult and pediatric asthma. J Allergy Clin Immunol 113 (2004) 407-414
13. Holgate S.T., and Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 368 (2006) 780-793
14. Bukstein D.A., Jones C.A., Ledford D.K., et al. Discussing the COSTS of asthma: Controlling Outcomes, Symptoms, and Treatment Strategies. Am J Manag Care 11 (2005) S318-S336
15. Brown R.H. Mechanisms of limited airway dimension with lung inflation. Pulm Pharmacol Ther 20 (2007) 118-125
16. Trampel R., Jensen J.H., Lee R.F., et al. Diffusional kurtosis imaging in the lung using hyperpolarized 3He. Magn Reson Med 56 (2006) 733-737
17. Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention. National Institutes of Health. NIH Publication No. 02-3659. Issued January 1995 (updated 2002)
18. http://www.ginasthma.org Accessed March 2007
19. Global Initiative for Asthma. Pocket Guide for Asthma Management and Prevention in Children. National Institutes of Health. NIH Publication No. 02-3659. Issued January 1995 (updated 2002)
20. http://www.ginasthma.org Accessed March 2007
21. Influenza and pneumococcal vaccination coverage among persons aged >65 years and persons aged 18-64 years with diabetes or asthma-United States, 2003-2004. MMWR 53 (2004) 1007-1012
22. American Lung Association Clinical Research Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 345 (2001) 1529-1536
23. Glezen J. Asthma, influenza, and vaccination. J Allergy Clin Immunol 118 (2006) 1199-1206
24. Prevention and control of influenza: Recommendations of the advisory committee on immunization practices. MMWR 53 (2004) 1007-1012
25. Kuzniar T.J., Morgenthaler T.I., Afessa B., and Lim K.G. Chronic cough from the patient's perspective. Mayo Clin Proc 82 (2007) 56-60
26. Morice A.H. The diagnosis and management of chronic cough. Eur Respir J 24 (2004) 481-492
27. Haque R.A., Usmarni O.S., and Barnes P.J. Chronic idiopathic cough: A discrete clinical entity?. Chest 127 (2005) 1710-1713
28. Enright P.L., McClelland R.L., Newman A.B., et al. Underdiagnosis and undertreatment of asthma in the elderly. Chest 116 (1999) 603-613
29. Celli B.R., MacNee W., and for the ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. [published correction appears in Eur Respir J. 2006;27:242]. Eur Respir J 23 (2004) 932-946
30. Ikaheimo P., Hartikainen S., Tuuponen T., et al. Comorbidity and medication load in adults asthmatics. Scand J Prim Health Care 23 (2005) 88-94
31. 2- adrenoceptor agonists: Cardiovascular safety in patients with obstructive lung disease. Drugs 65 (2005) 1595-1610
32. Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardiovascular effects of ß-agonists in patients with asthma and COPD: A meta-analysis. Chest 125 (2004) 2309-2321
33. Thomson N.C., and Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol 5 (2005) 57-63
34. Boto de los Bueis A., Pereira Vega A., Sanchez Ramos J.L., et al. Bronchial hyperreactivity in patients who inhale heroin mixed with cocaine vaporized on aluminum foil. Chest 121 (2002) 1223-1230
35. Hedley A.A., Ogden C.L., Johnson C.L., et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
36. Beuther D.A., Weiss S.T., and Sutherland R. Obesity and asthma. Am J Respir Crit Care Med 174 (2006) 112-119
37. Ford E.S. The epidemiology of obesity and asthma. J Allergy Clin Immunol 115 (2005) 897-909
38. Wang P.S., Avorn J., Brookhart M.A., et al. Effect of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension 46 (2005) 273-279
39. Kullowatz A., Kanniess F., Dahme B., et al. Association of depression and anxiety with health care use and quality of life in asthma patients. Respir Med 101 (2007) 638-644
40. Opolski M., and Wilson I. Asthma and depression: A pragmatic review of the literature and recommendations for future research. Clin Pract Epidemol Ment Health 1 (2005) 18. http://www.cpementalhealth.com/content/1/1/18 Accessed March 2007
41. Russo C., and Polosa R. TNF-alpha as a promising therapeutic target in chronic asthma: A lesson from rheumatoid arthritis. Clin Sci 109 (2005) 135-142
42. Sauleda J., Garcia-Palmer F.J., González G., et al. The activity of cytochrome oxidase is increased in circulating lymphocytes of patients with chronic obstructive pulmonary disease, asthma, and chronic arthritis. Am J Respir Crit Care Med 161 (2000) 32-35
43. Low R.B., Bielory L., Qureshi A.I., et al. The relation of stroke admissions to recent weather, airborne allergens, air pollution, seasons, upper respiratory infections, and asthma incidence, September 11, 2001, and day of the week. Stroke 37 (2006) 951-957
44. Kearney D.M., and Lockey R.F. Osteoporosis and asthma. Ann Allergy Asthma Immunol 96 (2006) 769-776
45. Israel E., Banerjee T.R., Fitzmaurice G.M., et al. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 345 (2001) 941-947
46. Maurya V., Gugnani H.C., Sarma P.U., et al. Sensitization to aspergillus antigens and occurrence of allergic bronchopulmonary aspergillosis in patients with asthma. Chest 127 (2005) 1252-1259
47. Schatz M. Interrelationships between asthma and pregnancy: A literature review. J Allergy Clin Immunol 103 (1999) S330-S336
48. Rahimi R., Nikfar S., and Abdollahi M. Meta-analysis finds use of inhaled corticosteroids during pregnancy safe: A systematic meta-analysis review. Hum Exp Toxicol 25 (2006) 447-452
49. NAEPP Expert Panel Report. Managing asthma during pregnancy: Recommendations for pharmacologic treatment- 2004 update. [published correction appears in J Allergy Clin Immunol. 2005;115:477]. J Allergy Clin Immunol 115 (2005) 34-46
50. Miller M.K., Lee J.H., Miller D.P., Wenzel S.E., and for the TENOR Study Group. Recent asthma exacerbations: A key predictor of future exacerbations. Respir Med 101 (2007) 481-489
51. Strek M.E. Difficult asthma. Proc Am Thorac Soc 3 (2006) 116-123
52. Peters S.P. Safety of inhaled corticosteroids in the treatment of persistent asthma. J Natl Med Assoc 98 (2006) 851-861
53. Barnes P.J. Distribution of receptor targets in the lung. Proc Am Thorac Soc 1 (2004) 345-351
54. Stempel D.A., Stoloff S.W., Carranza Rosenzweig J.R., et al. Adherence to asthma controller medication regimens. Respir Med 99 (2005) 1263-1267
55. Gibson P.G., Powell H., Coughlan J., et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev (2003) CD001117